• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Oncolysis of human gastric cancers by an E1B 55 kDa-deleted YKL-1 adenovirus.

作者信息

Lee Boyoung, Choi Jene, Kim Jaesung, Kim Joo-Hang, Joo Chul Hyun, Cho Young Keol, Kim Yoo Kyum, Lee Heuiran

机构信息

Department of Microbiology, University of Ulsan College of Medicine, P.O. Box 145, 138-736, Seoul, South Korea.

出版信息

Cancer Lett. 2002 Nov 28;185(2):225-33. doi: 10.1016/s0304-3835(02)00279-3.

DOI:10.1016/s0304-3835(02)00279-3
PMID:12169397
Abstract

Advanced gastric cancer cannot be treated with surgery or conventional cancer therapy, which has prompted a search for new therapeutic modalities. Previously, we and other groups showed that E1B 55 kDa-deleted recombinant adenoviruses, such as YKL-1, effectively replicate and induce cytotoxicity in p53-deficient cancer cells while sparing normal cells. Here, we investigated selective YKL-1 replication and resultant cytolysis in human gastric cancer cells. The cytopathic effects were obvious in all five gastric cancer cell lines we examined. Evaluation of p53 expression indicated that only the AGS cell line retained functionally normal p53. Nevertheless, AGS was 10-fold more sensitive to YKL-1 than the other cell lines. Transmission electron microscopy showed typical morphological alterations along with efficient replication of YKL-1 in AGS cells. Therefore, YKL-1 induces preferential cytotoxic effects in human gastric cancer cells in a p53-independent manner, making YKL-1 a promising therapeutic agent for human gastric cancers.

摘要

相似文献

1
Oncolysis of human gastric cancers by an E1B 55 kDa-deleted YKL-1 adenovirus.
Cancer Lett. 2002 Nov 28;185(2):225-33. doi: 10.1016/s0304-3835(02)00279-3.
2
An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.一种在p53基因缺失的人类肿瘤细胞中选择性复制的腺病毒突变体。
Science. 1996 Oct 18;274(5286):373-6. doi: 10.1126/science.274.5286.373.
3
Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: correlation with p53 functional status.缺失E1B 55 kDa的YKL-1重组腺病毒的溶瘤潜力:与p53功能状态的相关性
Int J Cancer. 2000 Nov 1;88(3):454-63. doi: 10.1002/1097-0215(20001101)88:3<454::aid-ijc19>3.0.co;2-t.
4
Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.用于癌症基因治疗的E1B基因减毒复制型腺病毒的评估。
Cancer Gene Ther. 2002 Sep;9(9):725-36. doi: 10.1038/sj.cgt.7700494.
5
p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection.p53状态不能决定E1B 55千道尔顿突变腺病毒裂解感染的结果。
J Virol. 1998 Dec;72(12):9479-90. doi: 10.1128/JVI.72.12.9479-9490.1998.
6
Will a twist of viral fate lead to a new cancer treatment?病毒命运的转折会带来新的癌症治疗方法吗?
Science. 1996 Oct 18;274(5286):342-3. doi: 10.1126/science.274.5286.342.
7
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.5型腺病毒复制中E1B-55K对p53的非依赖性和依赖性需求
J Virol. 1999 Jul;73(7):5333-44. doi: 10.1128/JVI.73.7.5333-5344.1999.
8
Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.一种纤维突变型E1B缺陷腺病毒对胶质瘤进行基因治疗时具有高度增强的细胞病变效应。
Cancer Res. 1999 Jul 15;59(14):3411-6.
9
Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.5型腺病毒E1B-55K蛋白单氨基酸取代突变体的分析
J Virol. 2001 May;75(9):4297-307. doi: 10.1128/JVI.75.9.4297-4307.2001.
10
Genetically modified adenoviruses against gliomas: from bench to bedside.抗胶质瘤的基因工程腺病毒:从实验台到临床应用
Neurology. 2004 Aug 10;63(3):418-26. doi: 10.1212/01.wnl.0000133302.15022.7f.

引用本文的文献

1
Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.重组内皮抑素基因腺病毒联合 E1B55KD 缺失型腺病毒对胃癌细胞的抗肿瘤作用
J Transl Med. 2013 Oct 14;11:257. doi: 10.1186/1479-5876-11-257.
2
Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.第一章---癌症终结者病毒及其增强治疗效果的方法。
Adv Cancer Res. 2012;115:1-38. doi: 10.1016/B978-0-12-398342-8.00001-X.
3
Morphology and infectivity of virus that persistently caused infection in an AGS cell line.
在AGS细胞系中持续引起感染的病毒的形态学和感染性。
Med Mol Morphol. 2011 Dec;44(4):213-20. doi: 10.1007/s00795-010-0530-3. Epub 2011 Dec 17.
4
Cytokine determinants of viral tropism.病毒嗜性的细胞因子决定因素。
Nat Rev Immunol. 2009 Sep;9(9):645-55. doi: 10.1038/nri2623. Epub 2009 Aug 21.